Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peramivir in Uncomplicated Influenza
NCT01224795Phase 3Withdrawn
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Oct 2010
- Primary completion
- Nov 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of peramivir in influenza, sponsored by BioCryst Pharmaceuticals, Inc.. Planned start Oct 2010; status: withdrawn.
02
Drugs
peramivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01224795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01224795.